Thursday, October 23, 2008

Hormone Therapy is Safe for BRCA1 Mutation Carriers

The J Natl Cancer Inst. has published reassuring findings from a case control study. Women with BRCA1 mutations have a lifetime risk for breast cancer of 60-80%. Many of these women undergo prophylactic oophorectomy (removal of the ovaries) before menopause as a way to lower their risk. This surgery can cause severe, sometimes disabling symptoms of menopause and really affect a woman's quality of life. Because of the concerns about breast cancer, these women are afraid to use hormone replacement to relieve symptoms.

This study, supported by the N.I.H., looked at 472 women and matched them with controls. They found that there was no evidence of higher breast cancer with hormone therapy use in BRCA1 mutation carriers and it even provided a surprising suggestion that hormones could be protective. This important study allows us to reassure women with BRCA1 mutations that use of menopausal hormones are OK to relieve severe symptoms of menopause.


Anonymous said...

Wow, that is amazing. Thanks for the info. I have a friend who is going through just what you say and I am going to tell her about this.

Cheap Viagra said...

the most interesting thing in this theme, is how the most minimal variable can affect in the genetic process.

Saul said...

Gosh, there is so much useful data above!
Diabetic recipes | nerd glasses | Roast recipes

personal injury said...

So, I do not actually believe it is likely to work.